Agency Information Collection Request. 60-Day Public Comment Request, 69207-69208 [2023-22158]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 192 / Thursday, October 5, 2023 / Notices
0910–0001. The collections of
information in 21 CFR 201.56 and
201.57 relating to certain prescription
product labeling requirements have
been approved under OMB control
number 0910–0572. The collections of
information pertaining to expedited
programs for serious conditions for
drugs and biologics and breakthrough
therapy-designation for drugs and
biologics have been approved under
OMB control number 0910–0765.
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
regulatory-information/search-fdaguidance-documents, or https://
www.regulations.gov.
Dated: October 2, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–22189 Filed 10–4–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–0008]
Radiological Devices Panel of the
Medical Devices Advisory Committee;
Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Radiological Devices
Panel of the Medical Devices Advisory
Committee. The general function of the
committee is to provide advice and
recommendations to the Agency on
FDA’s regulatory issues. The meeting
will be open to the public.
DATES: The meeting will take place
virtually on November 7, 2023, from 9
a.m. to 12:15 p.m. eastern time.
ADDRESSES: All meeting participants
will be heard, viewed, captioned, and
recorded for this advisory committee
meeting via an online teleconferencing
and/or video conferencing platform.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:37 Oct 04, 2023
Jkt 262001
FOR FURTHER INFORMATION CONTACT:
Jarrod Collier, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5214, Silver Spring,
MD 20993–0002, Jarrod.Collier@
fda.hhs.gov, 240–672–5763, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572) in the
Washington, DC area). A notice in the
Federal Register about last-minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s website at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before the meeting.
SUPPLEMENTARY INFORMATION:
Agenda: The meeting presentations
will be heard, viewed, captioned, and
recorded through an online
teleconferencing platform. On
November 7, 2023, the committee will
discuss and make recommendations on
the classification of blood irradiator
devices for the prevention of metastasis,
which are currently unclassified preamendments devices, to class III
(general controls and premarket
approval).
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its website prior to the
meeting, the background material will
be made publicly available on FDA’s
website at the time of the advisory
committee meeting, and the background
material will be posted on FDA’s
website after the meeting. Background
material and the link to the online
teleconference meeting room will be
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down and select the
appropriate advisory committee meeting
link. The meeting will include slide
presentations with audio components to
allow the presentation of materials in a
manner that most closely resembles an
in-person advisory committee meeting.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before October 25, 2023.
Oral presentations from the public will
be scheduled on November 7, 2023,
between approximately 9:20 a.m. and
10:20 a.m. eastern time. Those
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
69207
individuals interested in making formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before October 17, 2023. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
October 18, 2023.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Ann Marie
Williams at Annmarie.williams@
fda.hhs.gov or 240–507–6496 at least 7
days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/ucm111462.
htm for procedures on public conduct
during advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 29, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–22106 Filed 10–4–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0937–0025
Agency Information Collection
Request. 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
SUMMARY:
E:\FR\FM\05OCN1.SGM
05OCN1
69208
Federal Register / Vol. 88, No. 192 / Thursday, October 5, 2023 / Notices
Comments on the ICR must be
received on or before December 4, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041 and PRA@HHS.GOV.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0937–0025–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, PRA@
HHS.GOV or call (202) 264–0041 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
DATES:
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: U.S. Public
Health Service Commissioned Corps.
Type of Collection: Extension.
OMB No. 0937–0025.
Abstract: The Commissioned Corps of
the U.S. Public Health Service has a
need for the information in order to
assess the qualifications of each
applicant and make a determination
whether the applicant meets the
requirements to receive a commission.
The information is used to make
determinations on candidates/
applicants seeking appointment to the
Regular Corps and Ready Reserve Corps
to assess whether they are suitable for
life in the uniformed services based
upon a review of a variety of assessment
factors including, but not limited to:
personal adjustment, employment
history, character, and a candidate’s
prior history of service in one of the
uniformed services. Their potential for
leadership as a commissioned officer
and their ability to deal effectively with
people is evaluated.
ANNUALIZED BURDEN HOUR TABLE
Number of
reserve corps
respondents
Number
response per
respondent
Average
burden per
responses
(in hours)
Form name
Interested Health Professionals.
Health Professionals ...........
Prequalification Questionnaire.
Form PHS–50 ....................
6,000
1,000
1
10/60
1,167
3,000
500
1
15/60
875
References (college professors/teachers).
Health Professionals ...........
Form PHS–1813 ................
3,000
500
1
15/60
875
Addendum: Commissioned
Corps Personal Statement.
3,000
500
1
15/60
875
Total .............................
.............................................
........................
........................
........................
........................
3,792
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2023–22158 Filed 10–4–23; 8:45 am]
BILLING CODE 4150–49–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
regular corps
respondents
Type of
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
18:37 Oct 04, 2023
Jkt 262001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NCATS Conference Grant
Reviews.
Date: November 3, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marilyn Moore-Hoon,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Center for
Advancing Translational Sciences, National
Institutes of Health, 6701 Democracy
Boulevard, MSC 4874, Bethesda, MD 20892,
(301) 827–9549, mooremar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
Total
burden hours
Dated: September 29, 2023.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–22100 Filed 10–4–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 88, Number 192 (Thursday, October 5, 2023)]
[Notices]
[Pages 69207-69208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22158]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0937-0025
Agency Information Collection Request. 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
[[Page 69208]]
DATES: Comments on the ICR must be received on or before December 4,
2023.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 264-0041 and [email protected].
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0937-0025-60D and
project title for reference, to Sherrette A. Funn, email:
[email protected], [email protected] or call (202) 264-0041 the Reports
Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: U.S. Public Health Service Commissioned
Corps.
Type of Collection: Extension.
OMB No. 0937-0025.
Abstract: The Commissioned Corps of the U.S. Public Health Service
has a need for the information in order to assess the qualifications of
each applicant and make a determination whether the applicant meets the
requirements to receive a commission. The information is used to make
determinations on candidates/applicants seeking appointment to the
Regular Corps and Ready Reserve Corps to assess whether they are
suitable for life in the uniformed services based upon a review of a
variety of assessment factors including, but not limited to: personal
adjustment, employment history, character, and a candidate's prior
history of service in one of the uniformed services. Their potential
for leadership as a commissioned officer and their ability to deal
effectively with people is evaluated.
Annualized Burden Hour Table
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Number of Number Average burden
Type of respondent Form name regular corps reserve corps response per per responses Total burden
respondents respondents respondent (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Interested Health Professionals........... Prequalification 6,000 1,000 1 10/60 1,167
Questionnaire.
Health Professionals...................... Form PHS-50................. 3,000 500 1 15/60 875
-------------------------------------------------------------------------------
References (college professors/teachers).. Form PHS-1813............... 3,000 500 1 15/60 875
Health Professionals...................... Addendum: Commissioned Corps 3,000 500 1 15/60 875
Personal Statement.
-------------------------------------------------------------------------------
Total................................. ............................ .............. .............. .............. .............. 3,792
--------------------------------------------------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2023-22158 Filed 10-4-23; 8:45 am]
BILLING CODE 4150-49-P
